IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Clinical Update on IHL-42X for Obstructive Sleep Apnoea, page-55

  1. 935 Posts.
    lightbulb Created with Sketch. 392
    With COVID 19 continuing to create health issues around the world on a large scale, our upcoming results into ARDS is a massive announcement. ARDS without COVID 19 is a huge market anyhow, however it would certainly be very topical at this time. With no vaccines in sight, a treatment to reduce the severity will be extremely important going forward. I would say people have a matter of days to buy in if they so chose. IMO I think we will see some great upside!
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.